SG Americas Securities’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75M | Buy |
726,742
+30,835
| +4% | +$74.3K | 0.01% | 755 |
|
|
2025
Q1 | $1.54M | Buy |
695,907
+662,861
| +2,006% | +$1.46M | 0.01% | 808 |
|
|
2024
Q4 | $180K | Buy |
33,046
+2,239
| +7% | +$12.2K | ﹤0.01% | 1994 |
|
|
2024
Q3 | $256K | Buy |
+30,807
| New | +$256K | ﹤0.01% | 2024 |
|
|
2024
Q2 | – | Sell |
-52,753
| Closed | -$457K | – | 2679 |
|
|
2024
Q1 | $457K | Sell |
52,753
-41,003
| -44% | -$355K | ﹤0.01% | 1322 |
|
|
2023
Q4 | $614K | Buy |
+93,756
| New | +$614K | 0.01% | 1208 |
|
|
2022
Q4 | – | Sell |
-8,395
| Closed | -$214K | – | 2876 |
|
|
2022
Q3 | $214K | Sell |
8,395
-76,827
| -90% | -$1.96M | ﹤0.01% | 2021 |
|
|
2022
Q2 | $2.42M | Buy |
85,222
+82,360
| +2,878% | +$2.34M | 0.03% | 535 |
|
|
2022
Q1 | $101K | Buy |
2,862
+185
| +7% | +$6.53K | ﹤0.01% | 2459 |
|
|
2021
Q4 | $112K | Buy |
+2,677
| New | +$112K | ﹤0.01% | 2727 |
|
|
2021
Q3 | – | Sell |
-2,637
| Closed | -$110K | – | 3473 |
|
|
2021
Q2 | $110K | Buy |
+2,637
| New | +$110K | ﹤0.01% | 2369 |
|
|
2021
Q1 | – | Sell |
-24,000
| Closed | -$673K | – | 2974 |
|
|
2020
Q4 | $673K | Buy |
+24,000
| New | +$673K | ﹤0.01% | 1543 |
|